2018 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2016 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2010 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2017 | 0 | 3.493.845 | 0 | 1 | ||
2013 | 0 | 15.302.991 | 1.261.467 | 2 | ||
2011 | 0 | 2.997.196 | 223.480 | 1 | ||
2010 | 0 | 11.932.398 | 443.280 | 1 |
Total number of partners: 66
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 66
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2017-10-01 | EXPLORING THE NEUROLOGICAL EXPOSOME | NEUROSOME | participant | 3.493.845 | 15 |
2013-11-01 | Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex | EPISTOP | participant | 9.451.675 | 14 |
2013-10-01 | Local Immunomodulation around implants by innovative auxiliary hydrogel-based systems encapsulating autologous and phenotype controlled macrophages | IMMODGEL | participant | 5.851.316 | 8 |
2011-10-01 | Safety Evaluation of Adverse Reactions in Diabetes | SAFEGUARD | participant | 2.997.196 | 17 |
2010-02-01 | Consortium on Health and Ageing: Network of Cohorts in Europe and the United States | CHANCES | participant | 11.932.398 | 17 |